Probiotics for ulcerative colitis therapy: Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial. Lancet 1999;354:635–9.
D.R MackVolume:
95
Year:
2000
Language:
english
DOI:
10.1016/s0002-9270(99)00799-6
File:
PDF, 15 KB
english, 2000